ArticleArchives of microbiology2016
Aerobic and anaerobic cellulase production by Cellulomonas uda.
Article in Archives of microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 39 citations in OpenAlex.
- Fungal-bacterial interaction networks in lignocellulose degradation: an integrated ecological and mechanistic perspective.Biotechnology for biofuels and bioproducts · 2026Review
- Enhancing the biomethane production from lignocellulosic residues through bioaugmentation of anaerobic digestion.Bioprocess and biosystems engineering · 2025Article
- Coconut rhinoceros beetle, Oryctes rhinoceros (Coleoptera: Scarabaeidae), larval frass as plant fertilizer.Botanical studies · 2025Article
- Swine gut microbiome associated with non-digestible carbohydrate utilization.Frontiers in veterinary science · 2023Review
- Characterization of thermo/halo stable cellulase produced from halophilic Virgibacillus salarius BM-02 using non-pretreated biomass.World journal of microbiology & biotechnology · 2022Article
- The Structure of Stable Cellulolytic Consortia Isolated from Natural Lignocellulosic Substrates.International journal of molecular sciences · 2022Article
- Biodegradation of Polymers Used in Oil and Gas Operations: Towards Enzyme Biotechnology Development and Field Application.Polymers · 2022Review
- Optimization of bioprocesses with Brewers' spent grain andEngineering in life sciences · 2022Article
- A Combined Study on Optimization,Biochemistry research international · 2022Review
- Direct and Indirect Reduction of Cr(VI) by Fermentative Fe(III)-ReducingJournal of microbiology and biotechnology · 2021Article
- Endophytic Bacteria From the Roots of the Medicinal PlantFrontiers in microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellulomonas uda (DSM 20108/ATCC 21399) is one of the few described cellulolytic facultative anaerobes. Based on these characteristics, we initiated a physiological study of C. uda with the aim to exploit it for cellulase production in simple bioreactors with no or sporadic aeration. Growth, cellulase activity and fermentation product formation were evaluated in different media under both aerobic and anaerobic conditions and in experiments where C. uda was exposed to alternating aerobic/anaerobic growth conditions. Here we show that C. uda behaves as a true facultative anaerobe when cultivated on soluble substrates such as glucose and cellobiose, but for reasons unknown cellulase activity is only induced under aerobic conditions on insoluble cellulosic substrates and not under anaerobic conditions. These findings enhance knowledge on the limited number of described facultative cellulolytic anaerobes, and in addition it greatly limits the utility of C. uda as an 'easy to handle' cellulase producer with low aeration demands.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.